Imagion Biosystems Ltd. (AU:IBX)
ASX:IBX
Want to see AU:IBX full AI Analyst Report?
Total Valuation
Imagion Biosystems Ltd. has a market cap or net worth of AU$8.83M. The enterprise value is AU$4.47M.
Market CapAU$8.83M
Enterprise ValueAU$4.47M
Share Statistics
Imagion Biosystems Ltd. has 490,590,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding490,590,240
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Imagion Biosystems Ltd.’s return on equity (ROE) is 1.99 and return on invested capital (ROIC) is -882.39%.
Return on Equity (ROE)1.99
Return on Assets (ROA)-2.11
Return on Invested Capital (ROIC)-882.39%
Return on Capital Employed (ROCE)1.66
Revenue Per Employee0.00
Profits Per Employee-391.77K
Employee Count11
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Imagion Biosystems Ltd. is ―. Imagion Biosystems Ltd.’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio-3.21
Price to Fair Value-3.21
Price to FCF-1.72
Price to Operating Cash Flow-1.53
PEG Ratio0.02
Income Statement
In the last 12 months, Imagion Biosystems Ltd. had revenue of 0.00 and earned -4.31M in profits. Earnings per share was -0.02.
Revenue0.00
Gross Profit-8.81K
Operating Income-3.58M
Pretax Income-4.35M
Net Income-4.31M
EBITDA-3.58M
Earnings Per Share (EPS)-0.02
Cash Flow
In the last 12 months, operating cash flow was -4.04M and capital expenditures 4.00, giving a free cash flow of -4.04M billion.
Operating Cash Flow-4.04M
Free Cash Flow-4.04M
Free Cash Flow per Share>-0.01
Dividends & Yields
Imagion Biosystems Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.14
52-Week Price Change30.77%
50-Day Moving Average0.02
200-Day Moving Average0.02
Relative Strength Index (RSI)46.02
Average Volume (3m)16.05M
Important Dates
Imagion Biosystems Ltd. upcoming earnings date is Aug 27, 2026, TBA (Confirmed).
Last Earnings DateFeb 27, 2026
Next Earnings DateAug 27, 2026
Ex-Dividend Date―
Financial Position
Imagion Biosystems Ltd. as a current ratio of 0.48, with Debt / Equity ratio of -118.62%
Current Ratio0.48
Quick Ratio0.48
Debt to Market Cap0.37
Net Debt to EBITDA-0.20
Interest Coverage Ratio-4.23
Taxes
In the past 12 months, Imagion Biosystems Ltd. has paid -40.66K in taxes.
Income Tax-40.66K
Effective Tax Rate<0.01
Enterprise Valuation
Imagion Biosystems Ltd. EV to EBITDA ratio is -2.14, with an EV/FCF ratio of -1.89.
EV to Sales0.00
EV to EBITDA-2.14
EV to Free Cash Flow-1.89
EV to Operating Cash Flow-1.89
Balance Sheet
Imagion Biosystems Ltd. has AU$1.85M in cash and marketable securities with AU$2.56M in debt, giving a net cash position of -AU$716.72K billion.
Cash & Marketable SecuritiesAU$1.85M
Total DebtAU$2.56M
Net Cash-AU$716.72K
Net Cash Per Share>-AU$0.01
Tangible Book Value Per Share>-AU$0.01
Margins
Gross margin is -2293.56%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin-2293.56%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Imagion Biosystems Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-100.00%
EPS Growth Forecast68.62%